葵花药业：上半年归母净利润8130.99万元，同比下降83.28%

Core Viewpoint - The company reported a significant decline in both revenue and net profit for the first half of the year, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved a revenue of 1.31 billion yuan in the first half of the year, representing a year-on-year decrease of 48.17% [1] - The net profit attributable to shareholders was 81.31 million yuan, down 83.28% from 486 million yuan in the same period last year [1] - The basic earnings per share were reported at 0.14 yuan [1]